Concept:
Potassium homeostasis in chronic kidney disease (CKD) is tightly regulated by aldosterone-mediated potassium secretion in the cortical collecting duct principal cells via ROMK and BK channels.
Impairment in the renin-angiotensin-aldosterone axis commonly leads to out-of-proportion hyperkalemia and non-anion gap metabolic acidosis (Type 4 Renal Tubular Acidosis).
Explanation:
• In chronic kidney disease, tubulointerstitial injury and arteriolar hyalinosis characteristically damage the juxtaglomerular apparatus, impairing the production and release of active renin.
• The resulting state of hyporeninemic hypoaldosteronism (Type 4 RTA) causes deficient aldosterone synthesis by the adrenal zona glomerulosa.
• Aldosterone deficiency reduces the activity of the basolateral $Na^+/K^+$-ATPase and decreases apical epithelial sodium channels (ENaC) and renal outer medullary potassium (ROMK) channels in the collecting tubule.
• This impairs electrical driving forces and prevents tubular potassium excretion, resulting in persistent hyperkalemia even with modest reductions in GFR and strict dietary potassium restriction.
• FGF-23 is a phosphaturic hormone secreted by osteocytes that increases urinary phosphate excretion and downregulates $1\alpha$-hydroxylase, playing no direct role in primary potassium retention.
• While metabolic acidosis causes an extracellular shift of potassium, chronic persistent baseline hyperkalemia in tubulointerstitial CKD is primarily driven by hyporeninemic hypoaldosteronism.
Final Answer:
The most common underlying endocrine/tubular mechanism for persistent hyperkalemia in pediatric CKD is hyporeninemic hypoaldosteronism (Type 4 RTA).